December 22, 2008 - Medtronic Inc. today said it acquired the remaining 1.5 million shares of CryoCath Technologies Inc. so it is now 100 percent owned by Medtronic.

Medtronic exercised its right to compulsorily acquire the CryoCath shares under Section 51 of the Companies Act (Québec). The compulsory acquisition followed an offer dated October 3, 2008 for all of the CryoCath shares at a price of Cdn. $8.75 per CryoCath share, which had been accepted by shareholders holding approximately 96.3 percent of the CryoCath shares.

December 19, 2008 - GE Healthcare’s Medical Quality Improvement Consortium (MQIC) quality data system was selected by the Centers for Medicaid and Medicare Services (CMS) as a reporting registry for the 2008 program, and GE expects this registry certification to continue in 2009.

December 18, 2008 - MiCardia announced the successful implant in two patients with the new new Dynaplasty mitral valve repair technology at the department of cardiovascular surgery, University Hospital, Kiel, Germany, the first week of December.

This marks the commencement of the company’s European Dynamic Annuloplasty Activation (DYANA) Study designed to provide data for CE Mark of the company’s Dynaplasty technology.

December 18, 2008 - ZOLL Medical Corp. this week received FDA 510(k) clearance to market and sell the ZOLL R Series Code-Ready clinical defibrillator with a WiFi option that allows wireless communication between the defibrillator and standard hospital networks to help ensure code-readiness and download of patient data.

December 18, 2008 - Boston Scientific Corp. today announced enrollment of the first patient in the CABANA post-market approval study of the company’s Carotid WALLSTENT Monorail Endoprosthesis used in conjunction with its FilterWire EZ Embolic Protection System.

The first patient was enrolled in the CABANA Study by Rajesh M. Dave, M.D., chairman, endovascular medicine, Pinnacle Health Heart and Vascular Institute, Harrisburg Hospital, Harrisburg, PA.

December 18, 2008 - Abbott this week said it started the SPIRIT Small Vessel, a clinical trial evaluating a 2.25mm size of the XIENCE V Everolimus-Eluting Coronary Stent System.

The 2.25mm stent system would offer physicians an option for treating coronary artery disease in narrower vessels that is based on the proven efficacy, safety and deliverability of XIENCE V.

December 18, 2008 - Spectranetics Corp. this week said the FDA cleared the Cross-Pilot Laser Support Catheter used in ablation of arterial blockages.

The launch of the product will commence during the first quarter of 2009 in the U.S., Europe and Canada.

December 17, 2008 – Yesterday’s agreement between Spacelabs Healthcare and Uscom gives Spacelabs exclusive distribution of the USCOM 1A ultrasonic cardiac output monitor in the Americas, Europe, Middle East, Africa and India.

December 17, 2008 – In the latest MD Buyline survey, GE Healthcare Monitoring Solutions and Diagnostic Cardiology Services, which includes service for patient, telemetry and Holter monitors as well as cardiac stress, cardiology management and electrocardiograph systems, achieved higher rankings nearly across the board.

December 17, 2008 - Bioheart Inc. announced yesterday its plan to shift focus from several non-core technology platforms to concentrate on the treatment of patients suffering from heart failure.

Bioheart will spin out or sell off its interest in several non-core technology platforms to which it holds the rights to multiple patents and patents pending related to these non-core technologies as well as proprietary know-how and trade secrets. Animal data supporting the proof of concept for some of these technologies is also available from the company.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now